From Wikipedia, the free encyclopedia
Gestational trophoblastic disease is any type of abnormal proliferation of trophoblasts during pregnancy. Types include:
- abnormal placenta, mostly due to abnormal fertilization
- frank malignant tumors of trophoblast
- invasive mole, choriocarcinoma (CCA)
- placental site trophoblastic tumor (PSTT)
- epithelioid trophoblastic tumor (ETT)
- not true neoplasms, representing abnormally formed placentas
- exaggerated placenta site (EPS)
- placental site nodule (PSN)
[edit] Treatment
Methotrexate and dactinomycin are among the chemotherapy drugs proposed for this condition.[1]
Molar pregnancies may be considered benign melanoma.
[edit] See also
[edit] References
- ^ Abrão RA, de Andrade JM, Tiezzi DG, Marana HR, Dos Reis FJ, Clagnan WS (2007). "Treatment for low-risk gestational trophoblastic disease: Comparison of single-agent methotrexate, dactinomycin and combination regimens". Gynecologic Oncology 108: 149. doi:10.1016/j.ygyno.2007.09.006. PMID 17931696.
[edit] External links
